Lisata Therapeutics(LSTA) - 2024 Q1 - Quarterly Results

Exhibit 99.1 Lisata Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update Projected available cash to fund planned operations into early 2026 covering all studies through data Conference call scheduled for today at 4:30 p.m. Eastern Time BASKING RIDGE, NJ (May 9, 2024) – Lisata Therapeutics, Inc. (Nasdaq: LSTA) ("Lisata" or the "Company"), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious dise ...